Killander D - Search Results

1

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Killander D. Ewers SB, et al. Among authors: killander d. Breast Cancer Res Treat. 1992;24(2):115-26. doi: 10.1007/BF01961244. Breast Cancer Res Treat. 1992. PMID: 8443399

2

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.

Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D. Baldetorp B, et al. Among authors: killander d. Cytometry. 1992;13(6):577-85. doi: 10.1002/cyto.990130605. Cytometry. 1992. PMID: 1451590 Free article.

3

Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Rydén S, Killander D. Ewers SB, et al. Among authors: killander d. Acta Oncol. 1992;31(7):733-40. doi: 10.3109/02841869209083862. Acta Oncol. 1992. PMID: 1476753 Clinical Trial.

4

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Ewers SB, Attewell R, Baldetorp B, Borg A, Långström E, Killander D. Ewers SB, et al. Among authors: killander d. Breast Cancer Res Treat. 1992 Jan;20(2):93-108. doi: 10.1007/BF01834639. Breast Cancer Res Treat. 1992. PMID: 1554892

5

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

Fernö M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: killander d. Cytometry. 1992;13(3):241-9. doi: 10.1002/cyto.990130305. Cytometry. 1992. PMID: 1576890 Free article.

6

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: killander d. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

7

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: killander d. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

8

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. Borg A, et al. Among authors: killander d. Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070

9

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Among authors: killander d. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

10

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.

Olsson H, Ranstam J, Baldetorp B, Ewers SB, Fernö M, Killander D, Sigurdsson H. Olsson H, et al. Among authors: killander d. Cancer. 1991 Mar 1;67(5):1285-90. doi: 10.1002/1097-0142(19910301)67:5<1285::aid-cncr2820670502>3.0.co;2-q. Cancer. 1991. PMID: 1991290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters